Mimetogen

News


	05/01/12 Mimetogen Pharmaceuticals Inc. Appoints Kim Brazzell, Ph.D. as Chief Medical Officer


	26/06/11 Mimetogen Pharmaceuticals Inc. Announces Positive Top Line Data from Phase II Clinical Trial of MIM-D3 for Dry Eye Disease


	25/02/11 Mimetogen Pharmaceuticals Announces Completion of Series B Financing and Enrollment of 100th Patient in Phase II Trial


	22/11/10 Mimetogen Pharmaceuticals Announces Initiation of Phase II Clinical Trial of Novel NGF Mimetic in Patients with Dry Eye


	07/10/09 Mimetogen Pharmaceuticals Completes Key Equity Financing for Ophthalmology Drugs


	01/05/09 Mimetogen Pharmaceuticals Inc. Expands Its Board of Directors


	13/04/09 Mimetogen To Present Company at BioFinance Meeting


	30/03/09 Mimetogen To Present Pre-Clinical Dry Eye Data at ARVO Meeting


	24/09/08 World Sight Day, October 9, 2008


	19/09/07 Mimetogen Pharmaceuticals Inc. Featured In BioCentury\'s Bernstein Report on BioBusiness

1000 de La Gauchetière Street West, Suite 900. Montréal, Québec, H3B 5H4, Canada